Data are included as supplemental files, and the genomic data have been uploaded to Gene Expression Omnibus (GSE131363).

Introduction {#sec001}
============

Hundreds of scientific observations since the early 1900's suggest that female birds are able to bias the sexes of the offspring they produce in response to external cues \[[@pone.0232120.ref001]\]. Birds bias primary offspring sex ratios in response to a variety of environmental conditions, such as territory quality \[[@pone.0232120.ref002],[@pone.0232120.ref003]\], food availability \[[@pone.0232120.ref004],[@pone.0232120.ref005]\], and laying date \[[@pone.0232120.ref006],[@pone.0232120.ref007]\]. Both mate attractiveness \[[@pone.0232120.ref008],[@pone.0232120.ref009]\] and maternal condition \[[@pone.0232120.ref010],[@pone.0232120.ref011]\] also exert a significant influence on offspring sex ratios. In most cases, sex ratio manipulation happens without the loss of eggs or embryos in the laying sequence, which suggests that females can alter sex ratios prior to ovulation \[[@pone.0232120.ref012]\]. In birds, females are the heterogametic sex, contributing either a male-producing Z chromosome or a female-producing W chromosome. Segregation of these sex chromosomes within the germinal disc (GD), in which one is pulled into the polar body to be discarded while the other is kept in the oocyte, occurs just prior to ovulation \[[@pone.0232120.ref001],[@pone.0232120.ref013],[@pone.0232120.ref014]\]. A body of research suggests that hormones are likely mediators of sex ratio adjustment during this time because they can transduce environmental and social experiences into physiological responses, and treatment with multiple hormones has biased offspring sex ratios in birds \[[@pone.0232120.ref015]\].

Most mechanistic studies of sex ratio manipulation have focused on two hormones, testosterone and corticosterone, because they are necessary for normal reproductive functioning and elevations of both occur right before ovulation \[[@pone.0232120.ref016]\]. Females with elevated testosterone levels over a long period of time bias their offspring sex ratios towards males \[[@pone.0232120.ref017]--[@pone.0232120.ref020]\]. Rutkowska and Cichon \[[@pone.0232120.ref019]\] showed that female zebra finches (*Taeniopygia guttata*) injected with testosterone when clutches were initiated produced significantly more sons later in the clutch. Testosterone administered just prior to sex chromosome segregation has also resulted in male-biased sex ratios \[[@pone.0232120.ref021]\]. Corticosterone also triggers sex ratio biases, but the direction of the skew depends on the timing of exposure. Chronic elevations of corticosterone skew sex ratios towards a female bias \[[@pone.0232120.ref018],[@pone.0232120.ref022],[@pone.0232120.ref023]\] and laying hens that receive corticosterone treatment 4h pre-ovulation produce significantly more daughters \[[@pone.0232120.ref024]\]. However, a dose of corticosterone administered 5h prior to meiotic segregation results in male-biased sex ratios in laying hens and zebra finches \[[@pone.0232120.ref025],[@pone.0232120.ref026]\]. In addition, Aslam et al. \[[@pone.0232120.ref027]\] showed that corticosterone treatment influenced the relationship between body mass and sex ratios of unincubated eggs. These studies illustrate that treatment with testosterone and corticosterone can influence sex ratios of avian offspring. Further, treating birds with these hormones just hours prior to ovulation of a follicle can alter the sex chromosome that the ovulated follicle receives.

There are several proposed mechanisms to explain how hormones may act to influence the sex of the ovulated oocyte \[[@pone.0232120.ref001],[@pone.0232120.ref013]\]. There is evidence that centromere centrality on the chromosome (i.e., where spindle fibers attach to pull chromosomes apart) can influence which chromosome is retained in the egg and which is shuttled to the polar body \[[@pone.0232120.ref028],[@pone.0232120.ref029]\]. The size and position of centromeres in birds is particularly plastic and differs between the W and Z chromosome, because the W chromosome contains large telomeres \[[@pone.0232120.ref030]\], which could potentially influence the centrality of its centromere \[[@pone.0232120.ref001]\]. Sex steroids and glucocorticoids can influence telomere lengths \[[@pone.0232120.ref031],[@pone.0232120.ref032],[@pone.0232120.ref033]\], making the alteration of telomere lengths a potential mechanism underlying sex ratio adjustment in birds, though in these cases telomere lengths changed over a period of days or weeks. Thus it is unclear whether telomere lengths can be altered within hours, as would be necessary for peri-ovulatory sex ratio adjustment.

The W chromosome also contains far less negatively charged DNA compared to the Z chromosome \[[@pone.0232120.ref034]\]. Spindle fiber movement (via microtubules) is influenced by charged ion gradients and hormone-induced charge gradients within the GD could result in differential movement of the sex chromosomes and/or the entire spindle apparatus \[[@pone.0232120.ref013]\]. Several other factors, like centromere and kinetochore size, and epigenetic modifications, may also impact the number of spindle fiber attachments on the chromosome, either directly \[[@pone.0232120.ref035],[@pone.0232120.ref036]\] or by altering chromosome compaction \[[@pone.0232120.ref037]\]. The "centromere drive" hypothesis suggests that the number of microtubule attachments may influence which chromosomes are retained in the egg (\[[@pone.0232120.ref038]\], reviewed in \[[@pone.0232120.ref013]\]). Finally, spindle function could underlie differential retention of the sex chromosomes; work in horses, marsupials, and frogs showed that the spindle apparatus rotates just prior to anaphase I to determine the ultimate fate of the chromosomes \[[@pone.0232120.ref039],[@pone.0232120.ref040],[@pone.0232120.ref041]\].

Our aim was to examine how steroids (testosterone and corticosterone) affect the genomic processes that underlie sex ratio adjustments in domestic chickens *(Gallus gallus*). We injected laying hens subcutaneously with either a control, testosterone, or corticosterone solution just before meiotic segregation and collected GDs from the F1 follicles during sex chromosome segregation for RNA-seq analyses. We predicted that treatment with these hormones would alter the expression of genes involved in the process of sex chromosome segregation, specifically those involved in chromosome alignment, spindle-fiber formation, chromosome attachment, and chromosome movement towards the poles of the oocyte. Based on the hypothesized mechanisms presented above, we expect to see differences in the expression of genes controlling size/location of the centromere (e.g., via telomere lengths), ionic gradients, epigenetic modifications, and spindle attachments or function. The overall idea is that changes in the expression of key genes in combination with key differences between the W and Z chromosomes may influence which sex chromosome ends up in the egg, and which is sent to an unfertilizable polar body. To the best of our knowledge, this study is the first to test for an effect of steroid hormones on the differential segregation of sex chromosomes at the molecular level during meiosis.

Methods {#sec002}
=======

Animal husbandry and experimental timing {#sec003}
----------------------------------------

Single-comb Hy-Line W36 White Leghorn hens (n = 400) were reared on the floor according to Hy-Line guidelines until they reached reproductive maturity. We then transferred them to individual layer cages in a single room, where they had *ad libitum* access to food and water throughout this study. They were kept on a standard breeding light schedule of 16h light: 8h dark. In laying hens, ovulation occurs 15--30 minutes after oviposition of the previous egg \[[@pone.0232120.ref014]\]. We could predict the timing of ovulation of each individual bird used in the study by recording their egg-laying patterns. When hens reached 30 weeks of age (after egg production has maximized), we monitored hens between 0700 AM-- 1000 AM daily for 5 weeks, and determined the precise time that the egg was laid based on the rate of egg cooling using thermal imaging using a (Flir One Pro, Flir® Systems, Wilsonville, OR) as described in \[[@pone.0232120.ref042]\].

Hormone pilot study {#sec004}
-------------------

Prior to the start of the experiment, we did a pilot study to validate that our hormone injections were effective in raising hormone plasma levels for several hours after being administered. We subcutaneously injected 21 consistent layers between 0400AM-0500AM, which was the same timing planned for the full experiment. These birds were from the same flock used in our subsequent experiment, which is important given that the rates of hormone metabolism have been shown to vary among flocks \[[@pone.0232120.ref024]\]. The 21 birds were randomly split into 3 different treatments: (1) 7 birds received a control injection (0.5ml of peanut oil) (2) 7 birds received a testosterone injection (1.5mg testosterone dissolved in 0.5ml of peanut oil), and (3) 7 birds received a corticosterone injection (1.5mg of corticosterone dissolved in 0.5ml of peanut oil). Baseline blood (1.0ml) was collected just prior to giving the injection via venipuncture of the brachial vein. Blood was again collected at both 1h and 2h post-injection. All samples were kept on ice until transported back to the lab. Plasma was collected from the samples and stored at -80°C.

For the hormone extraction procedure, 20ul of each sample was pipetted into separate glass vials, and 3ml of diethyl ether was added to each vial. The vials were vortexed for 30 seconds, then placed into a centrifuge and spun at 4°C at 1800 rpm for 9 minutes. The samples were then kept at -80°C for 7 minutes. Following this step, the samples were thawed and the supernatant was immediately decanted into clean glass culture tubes and dried overnight. Hormone plasma levels were determined using a corticosterone ELISA kit (item no. 501320, Cayman Chemical) and a testosterone ELISA kit (ADI-901-065, Enzo Life Sciences). The extracted samples were suspended in assay buffer and 50ul of each sample was added to the wells for both kits used. The assays were conducted following the protocol given with each kit. Results were analyzed using a repeated measures ANOVA for each hormone using Statview© software (SAS institute, Cary, NC, USA).

Hormone administration and tissue collection {#sec005}
--------------------------------------------

Approximately 3--5 h before ovulation, the attachment of spindle fibers and segregation of sex chromosomes in the GD occurs \[[@pone.0232120.ref014]\], thus injections were timed for 5h prior to ovulation. The 165 most consistent layers were randomly assigned to receive one of the three treatments described above (testosterone, corticosterone, or control). At approximately 1.5h post-injection (which is 3.5h before ovulation), when the sex chromosomes should be segregating, all hens were killed via injection of 1ml Euthasol and the F1 follicles were collected. The GD region was excised from the F1 follicle, briefly washed in Krebs buffer to remove any yolk material and placed in 0.5mL reaction tube filled with 100μl of Buffer RL (Norgen Biotek Corp.). Then, 100μl of 70% ethanol was added to the sample and it was vortexed thoroughly until the GD material was completely broken down. The samples were placed in -80°C for future use. Eight samples were lost during sample collection due to the difficulty of excising the germinal disc, leaving a total of 157 valid GD samples collected across eight days between 18 April 2018 and 8 May 2018. Of these, we selected the 45 samples for each treatment with the best RNA yields after extraction, leaving 45 samples collected from testosterone-treated birds, 45 samples from corticosterone-treated birds, and 45 samples from the control birds.

RNA isolation, pooling, and quality assessment {#sec006}
----------------------------------------------

The RNA from the samples was extracted using the Norgen's Single Cell RNA Purification Kit (catalog no. 51800, Norgen Biotek Corp.). A Nanodrop© spectrophotometer (ND-1000 Nanodrop Technologies, Wilmington, DE, USA) was used to assess A260/A280 ratios for determination of initial RNA purity and concentration of each sample. To ensure adequate RNA quantity for analysis, we pooled nine GD region samples (8μl per replicate), ultimately creating 5 pooled replicates per treatment group. Final RNA integrity of each replicate was assessed on an Agilent 2100 Bioanalyzer instrument (Model 62939B, Agilent Technologies, Santa Clara, CA, USA) at the Georgia Genomics and Bioinformatics Core (GGBC) at the University of Georgia (Athens, GA).

RNA-seq library preparation and sequencing {#sec007}
------------------------------------------

The GGBC at the University of Georgia conducted all library preparation and sequencing. The KAPA Stranded mRNA-Seq kit was used for the construction of NGS stranded RNA library for each replicate (KK8421, KAPA Biosystems, Wilmington, MA, USA). All libraries were pooled together by qPCR using the Roche LightCycler 480 II (product no. 05015278001, Roche Molecular Systems, Inc., Pleasanton, CA, USA). For this step, the KAPA Library Quantification kit (Illumina) with qPCR Master Mix optimized for LightCycler 480 was used (KK4854, KAPA Biosystems, Wilmington, MA). Next, the pooled library underwent pre-sequencing quality control. The DNA concentration of the pooled library was quantified using the Qubit HS dsDNA assay (catalog no. Q32854, ThermoFisher Scientific, Waltham, MA, USA). The Fragment Analyzer Automated CE System (Advanced Analytical Technologies, Ankeny, IA, USA) was used to visual the size distribution of the library. Then, qPCR was performed using the same kit and PCR products were quantified as described above. The pooled libraries were sequenced on an Illumina NextSeq 500 for 150 cycles with a PE75 high output flow cell.

RNA-sequencing data processing and analysis {#sec008}
-------------------------------------------

Trimmomatic software, version 0.36, \[[@pone.0232120.ref043]\] was employed to remove adapters and quality trim raw reads; reads with a trimmed length below a 35-base threshold were discarded. Reads were assessed for quality using FastQC both before and after trimming \[[@pone.0232120.ref044]\]. Trimmed reads were aligned to the *Gallus gallus* genome (Ensemble Gallus_gallus-5.0, GCA_000002315.3) using Tophat2 \[[@pone.0232120.ref045]\] run at default settings and BAM files were name sorted prior to extraction of raw gene counts with HTSeq \[[@pone.0232120.ref046]\] for generation of the count matrix. The matrix contained 24,881 rows (genes) and after removal of rows containing low counts (\<10 reads) this was reduced to 17,319 rows. All analyses were carried out in R (version 3.4.3; R Development Core Team). The Bioconductor package *DESeq2* \[[@pone.0232120.ref047]\] was used to identify differentially expressed genes (DEGs) and calculate normalized gene counts. Pairwise comparisons between the corticosterone-treated GDs or testosterone-treated GDs vs control GDs were made and DEGs with a false discovery rate (FDR) ≤ 0.05 were considered statistically differentially expressed. The web-based Biological Database Network (bioDBnet) conversion utility \[[@pone.0232120.ref048]\] was used to extract gene symbols for the Ensembl gene IDs.

Gene set enrichment analyses {#sec009}
----------------------------

In order to better understand the potential roles played by up- and down-regulated genes from each hormone treatment, we performed a Gene Set Enrichment Analysis (GSEA) for each pairwise comparison \[[@pone.0232120.ref049]\] using the *fgsea* package in R \[[@pone.0232120.ref050]\]. The gene lists used were comprised of all identified genes ranked by -log~10~P\*sign (logFC) for each comparison. The gene sets used included the curated Kyoto Encyclopedia of Genes and Genomes (KEGG) (c2) and gene ontology (GO) biological process (c5) from the Molecular Signature Database (MSigDBv2.5, \[[@pone.0232120.ref051]\]). The significance was assessed with 10,000 permutations, with a significance cut-off set as a Benjamini-Hochberg adjusted p ≤ 0.05 \[[@pone.0232120.ref052]\]. Significant gene sets were visualized using Enrichment Map (nodes represent gene sets and edges represent mutual overlap) to cluster highly redundant gene sets into functional groups, which we defined using AutoAnnotate in Cytoscape (v3.6.1; \[[@pone.0232120.ref053]\]). We only show functional groups containing 5 or more gene sets.

Results {#sec010}
=======

Hormone pilot study {#sec011}
-------------------

Results from the hormone pilot study indicate that the injections of testosterone and corticosterone were effective in raising the respective hormone concentrations in the hens ([Fig 1](#pone.0232120.g001){ref-type="fig"}). Testosterone levels were significantly elevated above controls when compared to baseline concentrations at 1h and 2h post-injection (Treatment: F~1,18~ = 89.33, p \< 0.001, Time: F~2,18~ = 72.48, p \< 0.001) as was corticosterone (Treatment: F~1,18~ = 6.061, p \< 0.04, Time: F~2,16~ = 4.68, p = 0.02).

![Testosterone and corticosterone concentrations in plasma before and after an injection with testosterone (n = 7, 1.5mg in 0.5ml peanut oil), corticosterone (n = 7, 1.5mg in 0.5ml peanut oil), or control oil (n = 7, 0.5ml peanut oil).\
Letters above bars indicate significant differences. Bars indicate means ± SE.](pone.0232120.g001){#pone.0232120.g001}

Differentially Expressed Genes (DEGs) in response to hormone treatment {#sec012}
----------------------------------------------------------------------

We tested comparisons between corticosterone-treated versus control birds, and testosterone-treated versus control birds. An average of ca. 42 million trimmed, PE reads/sample were mapped to the *G*. *gallus* genome using Tophat2 with an average overall alignment rate of 93% and an average concordant alignment rate \> 88%. Only one gene, iodothyronine deiodinase 2 (DIO2), was differentially expressed between testosterone and control samples; this gene was upregulated in the samples from testosterone-treated hens ([S1 Table](#pone.0232120.s002){ref-type="supplementary-material"}). Thirteen DEGs were identified in the corticosterone-treated versus control group ([Fig 2](#pone.0232120.g002){ref-type="fig"}). Five of these genes, CTD small phosphatase like (CTDSPL) (also called SCP3), exostosin glycosyltransferase 2 (EXT2), leukemia inhibitory factor receptor alpha (LIFR), transcription factor 12 (TCF12), and SET domain containing lysine methyltransferase 7 (SETD7), are either directly involved in the process of oocyte maturation, have the potential to influence the ionic gradient within the GD, or can exert epigenetic modifications on the chromosomes. For the full list of DEGs see [S1 Table](#pone.0232120.s002){ref-type="supplementary-material"}.

![Heatmap depicting differentially expressed genes between control (light gray) and corticosterone (dark gray) treatments.\
Each column is a set of 9 pooled samples, and each row is a gene. Heatmaps are scaled across rows to allow for comparisons of gene expression across individuals. Color indicates log-transformed normalized counts; blue indicates relatively lower expression and red indicates relatively higher expression. Rows and columns are clustered using Euclidean distance.](pone.0232120.g002){#pone.0232120.g002}

Gene set enrichment analyses {#sec013}
----------------------------

Next, we used GSEA to identify sets of genes that are regulated in GDs from testosterone- and corticosterone-treated hens. For testosterone-treated hens, 59 gene sets (56 GO and 3 KEGG) were significantly enriched with genes in a positive direction (upregulated) in testosterone-treated hens relative to controls and 17 gene sets (16 GO and 1 KEGG) were enriched with genes in a negative direction (downregulated; full GSEA results can be found in [S2 Table](#pone.0232120.s003){ref-type="supplementary-material"}). We visualized gene sets relevant for sex determination using the Enrichment Map plug-in for Cytoscape. Within the upregulated gene sets, five overlapped to form a functional group related to cell cycle regulation ([Fig 3A](#pone.0232120.g003){ref-type="fig"}), one of which included genes directly related to nuclear chromosome segregation ([Fig 3B](#pone.0232120.g003){ref-type="fig"}). No relevant functional groups were found in downregulated gene sets.

![(A) Enrichment Map showing a functional group of gene sets related to cell cycle that were detected in a Gene Set Enrichment Analysis (GSEA) comparing testosterone- versus control-treated hens, one of which was nuclear chromosome segregation (highlighted in red). Only gene sets with p~adj~ \< 0.05 are included. Node size corresponds to gene set size. Normally, color would designate the direction the gene sets were altered (red = enriched in testosterone-treatment, blue = depleted in testosterone-treatment), but in this case, all were enriched in samples from testosterone-treated hens, so all are red. Line thickness connecting the gene set nodes represents the degree of gene overlap between the two sets. (B) GSEA enrichment plot for a select gene set. Black bars represent the position of members of the gene set in the ranked list together with the running enrichment score (ES; plotted in green). The adjusted p-value and normalized enrichment score (NES) are presented. Leading edge genes (i.e., those that contribute most to the ES) are highlighted in gray and can be found in [S2 Table](#pone.0232120.s003){ref-type="supplementary-material"}.](pone.0232120.g003){#pone.0232120.g003}

For corticosterone-treated hens, 86 gene sets (80 GO and 6 KEGG) were significantly upregulated in corticosterone-treated hens relative to controls and 87 gene sets (81 GO and 6 KEGG) were downregulated (full GSEA results can be found in [S3 Table](#pone.0232120.s004){ref-type="supplementary-material"}). Within upregulated gene sets, several gene sets overlapped to form function groups related to chromosome segregation, spindle organization, cell cycle, chromatin modification, and DNA repair ([Fig 4A](#pone.0232120.g004){ref-type="fig"}). Specifically, genes involved in chromosome segregation, regulation of microtubule-based processes, and telomere maintenance via recombination were positively related to corticosterone treatment ([Fig 4A](#pone.0232120.g004){ref-type="fig"}). Within downregulated genes sets, 17 gene sets overlapped to form a functional group related to ion transport ([Fig 3A](#pone.0232120.g003){ref-type="fig"}), one of which included genes directly involved in anion transport ([Fig 4B](#pone.0232120.g004){ref-type="fig"}).

![(A) Enrichment Map showing functional groups (shaded in gray) of gene sets detected in a Gene Set Enrichment Analysis (GSEA) comparing corticosterone- versus control-treated hens; select gene sets are highlighted in red. Only functional groups containing ≥ 5 gene sets with p~adj~ \< 0.05 are included. Node size corresponds to gene set size and color designates the direction the gene sets were altered (red = enriched in corticosterone-treatment, blue = depleted in corticosterone-treatment). Line thickness connecting the gene set nodes represents the degree of gene overlap between the two sets. (B) GSEA enrichment plot for select gene sets. Black bars represent the position of members of the gene set in the ranked list together with the running enrichment score (ES; plotted in green). The adjusted p-value and normalized enrichment score (NES) are presented. Leading edge genes (i.e., those that contribute most to the ES) are highlighted in gray can be found in [S2 Table](#pone.0232120.s003){ref-type="supplementary-material"}.](pone.0232120.g004){#pone.0232120.g004}

Discussion {#sec014}
==========

Both corticosterone and testosterone treatment, given at the time sex chromosomes segregate in hens, triggered significant effects on both expression of individual genes and of gene networks in the preovulatory GD. Testosterone's influences appeared to be less dramatic than those triggered by corticosterone treatment. Our results showed only one DEG between hens treated with testosterone 5h prior to ovulation and hens that received a control injection; This gene (DIO2) was upregulated in hens treated with testosterone, but it is not known to exhibit functions that would likely influence sex chromosome movement. Corticosterone treatment, on the other hand, triggered downregulation of 13 DEGs, 3 of which are particularly interesting in terms of how they may play into an existing hypothesized mechanism for how sex ratio adjustment occurs. Furthermore, both testosterone and corticosterone treatment resulted in enriched gene sets related to sex ratio adjustment. Altogether, these data suggest exposure to steroids, particularly corticosterone, has the potential to influence many of the mechanisms underlying sex determination, which we discuss in detail below.

Corticosterone treatment had the strongest effect, leading to the downregulation of several DEGs with the potential to adjust sex ratios based on 4 hypothesized mechanisms ([Fig 5](#pone.0232120.g005){ref-type="fig"}). EXT2 encodes a protein involved in the biosynthesis of heparin sulfate, a molecule located on the cell surface and known for its extreme negative charge due to sulfate and carboxyl groups \[[@pone.0232120.ref054],[@pone.0232120.ref055]\]. Spindle function and movement of chromosomes within the cell is controlled by nanoscale electrostatic forces \[[@pone.0232120.ref056]\]. Perhaps if the biosynthesis of heparin sulfate is reduced, the cell surface would be less negatively charged. Since the Z chromosome contains more negatively charged DNA compared to the W \[[@pone.0232120.ref034]\], this could potentially make the Z chromosome more likely to migrate towards the surface of the oocyte (and thus the polar body) (hypothesis 2, [Fig 5](#pone.0232120.g005){ref-type="fig"}). This would result in more female offspring, as has been shown to occur as a result of both chronic exposure to and low-dose acute treatment with corticosterone \[[@pone.0232120.ref023],[@pone.0232120.ref024]\].

![Differentially Expressed Genes (DEGs) (all were downregulated) and significantly enriched GO terms in corticosterone compared to control-treated birds that may function in each of the proposed hypotheses for sex ratio adjustment in birds.\
Plus and minus signs indicate the direction of the correlation with corticosterone treatment.](pone.0232120.g005){#pone.0232120.g005}

CTDSPL (also called SCP3) encodes for a protein that is part of the synaptonemal complex, which is a meiosis-specific structure that is responsible for the pairing of the homologous chromosomes \[[@pone.0232120.ref057]\]. Prior work suggests this gene is sensitive to hormone levels and lower expression is associated with the disruption of meiotic progression \[[@pone.0232120.ref058]\]. It is possible that downregulating this gene could lead to fewer links between homologous chromosomes, potentially altering the ability of spindle fibers to attach (hypothesis 3, [Fig 5](#pone.0232120.g005){ref-type="fig"}).

Finally, SETD7 encodes for a histone-lysine methyltransferase that induces methylaton of histone 3 at lysine 4 (H3K4) \[[@pone.0232120.ref059]\]. In humans and mice, demethylation at this site is thought to contribute to physical organization of the centromere \[[@pone.0232120.ref060]\], a factor that is critically important in the connection of spindle fibers. Whether the activity of this methyltransferase can differentially influence the histones in the W versus Z chromosome remains unclear. However methylation at this site also blocks nucleotide-based methylation at CpG sites \[[@pone.0232120.ref061]\]. The W and Z chromosomes are differentially sensitive to nucleotide-based methylation, because the Z chromosome contains a 460-kb long region on its short arm where CpG sites are highly methylated during development \[[@pone.0232120.ref062]\]. Work in plants shows that the level of DNA methylation can influence segregation distortion \[[@pone.0232120.ref063]\], though we could not find published tests of this in animal systems. If methylation also controls chromosome movement in animals, this could provide a path by which SETD7 may be involved in directing how the two chromosomes migrate during meiotic segregation thereby skewing sex ratios of birds (hypothesis 3, [Fig 5](#pone.0232120.g005){ref-type="fig"}). Of the remaining DEGs, two are known to function in the process of oocyte maturation. LIFR participates in the LIF/STAT3 pathway, which is important in oocyte maturation \[[@pone.0232120.ref064]\]. FASN is involved in lipogenic activity of oocytes \[[@pone.0232120.ref065]\] and was also previously shown to be sensitive to glucocorticoids in mammals \[[@pone.0232120.ref066]\]. While more work needs to be done to determine whether the activity of these genes influences W and Z chromosomal segregation, and whether they directly influence sex determination, the current study suggests they may be involved in mechanisms by which steroids influence sex ratios.

While examining expression patterns of individual genes can yield important results, genes do not act on their own, but instead act in concert within a network of genes. GSEA results indicated that both testosterone and corticosterone treatments triggered enrichment of gene sets that are likely important in the process of sex determination. In corticosterone-treated hens, the gene sets that function in telomere maintenance via recombination and centromere complex assembly were both upregulated and could contribute to the first hypothesis concerning centromere centrality ([Fig 5](#pone.0232120.g005){ref-type="fig"}) \[[@pone.0232120.ref001]\]. Downregulated gene sets in corticosterone-treated hens overlapped to form a functional group related to ion transport, the function of which could potentially alter the electrochemical gradient in the GD (hypothesis 2, [Fig 5](#pone.0232120.g005){ref-type="fig"}). We also found functional groups of upregulated gene sets related to spindle organization, which could influence the number of spindle attachments and determine which sex chromosome is retained (hypothesis 3, [Fig 5](#pone.0232120.g005){ref-type="fig"}). Finally, upregulated gene sets, including chromosome segregation and establishment of spindle orientation, support the spindle flip hypothesis (hypothesis 4, [Fig 5](#pone.0232120.g005){ref-type="fig"}), where the spindle flips just before ovulation to control which set of chromosomes are retained in the egg \[[@pone.0232120.ref039]--[@pone.0232120.ref041]\]. Interestingly, chromosome segregation and spindle are two gene sets that were also enriched in hens that produce female-biased eggs \[[@pone.0232120.ref067]\]. Hypothesis 2 and 3 received the most support suggesting corticosterone may primarily skew sex ratios through manipulation of the ion gradient and/or spindle attachments.

Testosterone-treated GDs had fewer enriched gene sets that were relevant to the process of meiosis, though there was a functional group of upregulated gene sets controlling cell cycle processes. Perhaps the most interesting enriched gene set in testosterone-treated hens is nuclear chromosome segregation, which was also upregulated in corticosterone-treated hens. Given that both testosterone and corticosterone trigger skews in offspring sex ratios, perhaps they both do so through modifications of genes found in this particular gene set. It is difficult to explain why the two hormones were correlated with the gene sets in the same direction, given that they generally exert opposite effects on sex ratios. However, like testosterone treatment, acute treatment with corticosterone has elicited male-biased sex ratios in previous work \[[@pone.0232120.ref025],[@pone.0232120.ref026]\], suggesting genes involved in nuclear chromosome segregation are worth exploring further. We thought that an elevation of corticosterone in response to testosterone treatment may explain this, but after quantifying corticosterone in plasma one hour after testosterone injection, we saw no such elevation (data not shown).

The data presented herein provide mounting evidence that environmental variables influence sex ratios through the actions of hormones, particularly corticosterone. We additionally present some functionally relevant candidate genes and gene sets that can be further tested for influences on the process of sex ratio adjustment. It is particularly important for future work to consider how the W and Z chromosomes may be differentially sensitive to the functions of these gene sets to better elucidate how their final orientation and/or movement may be influenced. For example, given potential charge differences between the two chromosomes (Z contains more negatively charged DNA compared to the W \[[@pone.0232120.ref034]\], it is relatively easy to see how processes that could control ion gradients within the GD could ultimately determine position of the sex chromosomes. If there are differences in centromere size between the two chromosomes, which has not yet been tested, altering processes that influence microtubule and/or protein attachments to the centromere could disproportionately influence one sex chromosome over another. The W chromosome does contain a mega-telomere not found in the Z chromosome \[[@pone.0232120.ref030]\], suggesting the gene set related to telomere maintenance could exert a larger effect on centromere centrality on the W chromosome, ultimately influencing the direction in which it is pulled. Future studies should also test whether the electrochemical gradient within the GD corresponds to retention of a particular sex chromosome, and whether silencing genes in the identified pathways influences the direction of sex chromosome movement.

To date, knowledge about the process of meiotic segregation in birds is extremely limited. Our data provide insight not only into potential mechanisms of sex ratio adjustment, but also into gene pathways that may be involved in meiosis in birds. It is now possible to compare these findings with what is already known about this process in other systems to determine whether we can use mechanisms from other systems to further our understanding of meiotic processes in birds.
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5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: This genomic study has been properly designed and performed. I do not have any remarks concerning methodology of the study including genomic tools and statistics used. However, since the small number of the studies in this area I have few comments to the general idea of the study.

1\. Authors investigate the influence of two hormones on sex selection in hen. One of these hormones, namely corticosterone, plays a role of stress hormone in birds (as cortisol does in mammals). So maybe the hypotheses of sex selection given in the paper should also include the idea that stress factors (resulting in corticosterone release) bias offspring sex ration in female birds. If there is no stress (no corticosterone release) the standard "physiological setting" of sex selection is male-directed. This could explain obtained data that testosterone treatment resulted in significant regulation of only one gene. This is surprising since the testosterone administration resulted in significant increase of plasma testosterone level but the gene expression in GD seem to be unaffected. Bearing in mind the number of genes investigated in the study the number of differentially regulated genes by testosterone is quite small.

2\. One of the drawbacks of this paper is lack of clinical evaluation of treatments applied. In my opinion part of the birds from each experimental group should be kept further for the evaluation of male and female progeny ratio produced after treatment. Therefore few questions arises:

• We have here the data shoving effectiveness of hormones administration (increased plasma level of both hormones after administration -- Fig 1) but we do not know whether i.e. corticosterone administration influenced also endogenous testosterone and vice versa.

• Moreover, we do not know whether these treatment in fact changed male or female embryos ratio, so the study evaluates only the influence of the administration of these two hormones on gene expression in GD of F1 follicles but not on offspring sex selection.

• Data cited by the Authors suggest the influence of time of hormones administration before ovulation on the offspring sex selection. As I assume by administering the hormone roughly 5 hours before ovulation the Authors expected the skew toward male offspring. But why they decide to select the timepoint 5 hours before ovulation and not i.e. 3 hours before ovulation.

3\. Why Authors did not validate obtained results by Real-time PCR and were not trying to measure the level of proteins encoded by regulated genes. There are some suggestions in the paper that post-translational modifications could play here the important role, so the question arises whether the pure genomic approach is sufficient to give any hypotheses concerning sex selection.

4\. Did Authors received in genomic analyses also the significantly regulated unknown genes? Since the process of sex determination in bird offspring is in fact not well understood maybe the key role in this process play genes (and proteins) not previously described (and not taken into consideration in ontology analyses by different software).

Reviewer \#2: Offspring primary sex ratio bias in birds has been a very popular topic and the idea that outcome of meiotic division could be non-random inspires both basic and applied research. The study by Wrobel at al. is a step forward into investigations on how hormonal levels in the female just prior to ovulation could affect outcome of sex-determine meiotic division in birds. This is probably the second study that looks at gene expression in the germinal disk in avian pre-ovulatory oocytes (after Aslam et al 2015), and the first one that does it following manipulation of hormones.

Authors demonstrate that injections of hormones affect gene expression patters in the germinal disk, but do not study the outcome of meiosis in those disks, as this would probably be not technically possible. However, they also do not provide information on how accurate are testosterone and corticosterone manipulations in altering offspring primary sex ratios. Recent meta-analyses (Merkling et al. 2018 and Podmokla et al. 2018) show that such effects are rather weak and more likely to occur in response to testosterone manipulation. Thus, the current study provides some valuable new data, but leaves several questions still open.

The experimental design is appropriate and sample sizes are good. The pilot study reassures that hormonal injections are effective. Molecular analyses are carried out up the standards.

I have reviewed this manuscript before, and currently, I was happy to find that the presentation of the study has greatly improved. Few remaining issues are listed below.

Line 70 -- Sex steroids and glucocorticoids can influence telomere length. Please specify the tissue in which the cited references studied telomere length.

Line 101-2- The current study does not look at the differential segregation of the sex chromosomes.

Line 225 -- Please check degrees of freedom for the denominators.

Line 646 -- Should be "selected", this also refers also lines 653, 657.

Supplementary materials are incomplete -- original data for plasma hormone levels following injection of the hens is not provided.
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Reviewer \#2: No
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While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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1\. Authors investigate the influence of two hormones on sex selection in hen. One of these hormones, namely corticosterone, plays a role of stress hormone in birds (as cortisol does in mammals). So maybe the hypotheses of sex selection given in the paper should also include the idea that stress factors (resulting in corticosterone release) bias offspring sex ration in female birds. If there is no stress (no corticosterone release) the standard "physiological setting" of sex selection is male-directed. This could explain obtained data that testosterone treatment resulted in significant regulation of only one gene. This is surprising since the testosterone administration resulted in significant increase of plasma testosterone level but the gene expression in GD seem to be unaffected. Bearing in mind the number of genes investigated in the study the number of differentially regulated genes by testosterone is quite small.

We thank the reviewer for this suggested hypothesis, and we now include it in the discussion (Lines 360-375).

2\. One of the drawbacks of this paper is lack of clinical evaluation of treatments applied. In my opinion part of the birds from each experimental group should be kept further for the evaluation of male and female progeny ratio produced after treatment. Therefore few questions arises:

• We have here the data shoving effectiveness of hormones administration (increased plasma level of both hormones after administration -- Fig 1) but we do not know whether i.e. corticosterone administration influenced also endogenous testosterone and vice versa.

We agree that it would be nice to have these data. We no longer have the plasma from the pilot hormone validation portion of the study, however in future studies, it would be a good idea to see if the testosterone treatment influences hormone concentrations and vice versa. The fact that we saw quite different effects in response to corticosterone and testosterone treatments indicates, however, that the two hormones were not likely acting on the genes involved in sex ratio manipulation via effects on one another. We did add a discussion point on this (Lines 355-359).

• Moreover, we do not know whether these treatment in fact changed male or female embryos ratio, so the study evaluates only the influence of the administration of these two hormones on gene expression in GD of F1 follicles but not on offspring sex selection.

We agree that this is a limitation of the study, and when we were in the planning stages of the work, we brainstormed every possible way to get data on the sex ratio effects. However, we were limited by the number of birds that were laying at the exact intervals we needed, and we were not able to spare enough of them for a robust concurrent analyses of sex ratio effects. In the samples that we collected for gene expression analyses, it was impossible to determine sex because the chromosomes had not yet segregated. Despite this, we now know that these two hormones influence gene pathways related to meiotic segregation, and we can now take additional steps to manipulate these pathways and look at the outcomes on offspring sex. We added a discussion point on this (Lines 366-375).

• Data cited by the Authors suggest the influence of time of hormones administration before ovulation on the offspring sex selection. As I assume by administering the hormone roughly 5 hours before ovulation the Authors expected the skew toward male offspring. But why they decide to select the timepoint 5 hours before ovulation and not i.e. 3 hours before ovulation.

We chose 5h prior to ovulation because, according to previous research, meiotic segregation occurs 3-5h prior to ovulation. In addition, in our own previously published studies, we show that injection of these same amounts of these hormones at 5h prior to ovulation triggers sex ratio skews. So, we chose to use these exact same treatments to look at gene expression. We've attempted to clarify this in our methods section (Lines 149-151).

3\. Why Authors did not validate obtained results by Real-time PCR and were not trying to measure the level of proteins encoded by regulated genes. There are some suggestions in the paper that post-translational modifications could play here the important role, so the question arises whether the pure genomic approach is sufficient to give any hypotheses concerning sex selection.

This is our first step. Due to the small amount of DNA that we get out of the germinal discs, we did not have enough to run both RNA seq and real-time quantitative PCR. In addition, because it was mostly gene networks that changed (rather than individual genes), this made it difficult to choose a subset to validate for this current paper. For future studies, we hope to perform several tests to validate the differences in the expression of the major gene networks presented in this paper.

4\. Did Authors received in genomic analyses also the significantly regulated unknown genes? Since the process of sex determination in bird offspring is in fact not well understood maybe the key role in this process play genes (and proteins) not previously described (and not taken into consideration in ontology analyses by different software).

Thanks for this suggestion. In the control-corticosterone comparison, there was only one differentially expressed gene that was unidentified, and in the control-testosterone comparison, there were none. We now indicate that there is an affected gene of unknown function in the presentation of results (Line 239), and also include a line in the discussion about the potential for that gene to have a function related to the process of sex determination (Lines 321-322).

Reviewer \#2: Offspring primary sex ratio bias in birds has been a very popular topic and the idea that outcome of meiotic division could be non-random inspires both basic and applied research. The study by Wrobel at al. is a step forward into investigations on how hormonal levels in the female just prior to ovulation could affect outcome of sex-determine meiotic division in birds. This is probably the second study that looks at gene expression in the germinal disk in avian pre-ovulatory oocytes (after Aslam et al 2015), and the first one that does it following manipulation of hormones.

Authors demonstrate that injections of hormones affect gene expression patters in the germinal disk, but do not study the outcome of meiosis in those disks, as this would probably be not technically possible. However, they also do not provide information on how accurate are testosterone and corticosterone manipulations in altering offspring primary sex ratios. Recent meta-analyses (Merkling et al. 2018 and Podmokla et al. 2018) show that such effects are rather weak and more likely to occur in response to testosterone manipulation. Thus, the current study provides some valuable new data, but leaves several questions still open.

We now provide information about the accuracy of testosterone and corticosterone treatment in sex ratio adjustment, and discussion about how likely it is that these hormones are skewing sex ratios. Generally, in our previous studies, the manipulations that we use here triggered 70% of hens to skew sex ratios in one direction or the other (depending on the hormone). We attempted to account for the 30% that don't by pooling the germinal discs with the hope that the majority (70%) of the germinal discs in each pooled sample would be from hens that skewed their sex ratios in response to the treatment. Given that we now have gene pathways and genes that were differentially expressed in response to these treatments, the next step is to examine whether manipulation of those genes actually results in se ratio skews. See discussion (Lines 360-375) for our added discussion of this).

The experimental design is appropriate and sample sizes are good. The pilot study reassures that hormonal injections are effective. Molecular analyses are carried out up the standards.

I have reviewed this manuscript before, and currently, I was happy to find that the presentation of the study has greatly improved. Few remaining issues are listed below.

Line 70 -- Sex steroids and glucocorticoids can influence telomere length. Please specify the tissue in which the cited references studied telomere length.

We now specify the tissue in which telomere lengths changed (lines 71-75)

Line 101-2- The current study does not look at the differential segregation of the sex chromosomes.

Thank you for catching this. We have now reworded the sentence indicated.

Line 225 -- Please check degrees of freedom for the denominators.

We have checked and corrected the degrees of freedom for the denominators. Thanks for catching this error.

Line 646 -- Should be "selected", this also refers also lines 653, 657.

We have made this change.

Supplementary materials are incomplete -- original data for plasma hormone levels following injection of the hens is not provided.

We have now uploaded the data for the plasma hormone injections as the supplementary materials.
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2\. In your Methods section, please provide additional details regarding the animals used in your study and ensure you have described the source. For more information regarding PLOS\' policy on materials sharing and reporting, see <https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-materials>.\"

We now include details about where we got our birds.

3\. As part of your revision, please complete and submit a copy of the ARRIVE Guidelines checklist, a document that aims to improve experimental reporting and reproducibility of animal studies for purposes of post-publication data analysis and reproducibility: <https://www.nc3rs.org.uk/arrive-guidelines>. Please include your completed checklist as a Supporting Information file. Note that if your paper is accepted for publication, this checklist will be published as part of your article.

We have completed and uploaded this checklist.

4\. In your Methods section, please include a comment about the state of the animals following this research. Were they euthanized or housed for use in further research? If any animals were sacrificed by the authors, please include the method of euthanasia and describe any efforts that were undertaken to reduce animal suffering.

We now include a comment that birds not used for this work were transferred to another project.

5\. We note that you are reporting an analysis of a microarray, next-generation sequencing, or deep sequencing data set. PLOS requires that authors comply with field-specific standards for preparation, recording, and deposition of data in repositories appropriate to their field. Please upload these data to a stable, public repository (such as ArrayExpress, Gene Expression Omnibus (GEO), DNA Data Bank of Japan (DDBJ), NCBI GenBank, NCBI Sequence Read Archive, or EMBL Nucleotide Sequence Database (ENA)). In your revised cover letter, please provide the relevant accession numbers that may be used to access these data. For a full list of recommended repositories, see <http://journals.plos.org/plosone/s/data-availability#loc-omics> or <http://journals.plos.org/plosone/s/data-availability#loc-sequencing>.

These data have been uploaded to Gene Omnibus and we have included an accession number

6\. We note that you have included the phrase "data not shown" in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

We have removed this statement.

7\. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: <http://journals.plos.org/plosone/s/supporting-information>.
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Reviewer \#1: All comments have been addressed

Reviewer \#2: All comments have been addressed
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2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: No
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3\. Has the statistical analysis been performed appropriately and rigorously?
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4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.
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5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.
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